Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services—part 2 of 6
Janice M. Ranson, Timothy Rittman, Shabina Hayat, et al.
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 75

Showing 26-50 of 75 citing articles:

Interest in genetic susceptibility testing and disclosure of AD dementia risk in cognitively normal adults: a survey study
Lisa Waterink, Larissa A Masselink, Sven J. van der Lee, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Integrating AI in fighting advancing Alzheimer: diagnosis, prevention, treatment, monitoring, mechanisms, and clinical trials
Francesco Angelucci, Alice Ruixue Ai, Lydia Piendel, et al.
Current Opinion in Structural Biology (2024) Vol. 87, pp. 102857-102857
Closed Access | Times Cited: 3
Smart Solutions for Detecting, Predicting, Monitoring, and Managing Dementia in the Elderly: A Survey
Sampson Addae, Jungyoon Kim, A.J.E. Smith, et al.
IEEE Access (2024) Vol. 12, pp. 100026-100056
Open Access | Times Cited: 3
Repetitive Transcranial Magnetic Stimulation-Mediated Neuroprotection in the 5xFAD Mouse Model of Alzheimer’s Disease Through GABRG2 and SNAP25 Modulation
Jinyang Wang, Chenming Zhou, Zhimin Huang, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 3
The emerging field of non-invasive brain stimulation in Alzheimer’s disease
Giacomo Koch, Daniele Altomare, Alberto Benussi, et al.
Brain (2024)
Open Access | Times Cited: 3
Using Hypothesis-Led Machine Learning and Hierarchical Cluster Analysis to Identify Disease Pathways Prior to Dementia: Longitudinal Cohort Study
Shih‐Tsung Huang, Fei‐Yuan Hsiao, Tsung‐Hsien Tsai, et al.
Journal of Medical Internet Research (2023) Vol. 25, pp. e41858-e41858
Open Access | Times Cited: 8
Brain Health and Cognition in Older Adults: Roadmap and Milestones towards the Implementation of Preventive Strategies
Federico Emanuele Pozzi, Giulia Remoli, Lucio Tremolizzo, et al.
Brain Sciences (2024) Vol. 14, Iss. 1, pp. 55-55
Open Access | Times Cited: 2
Secondhand Smoke Exposure and Risk of Dementia in Nonsmokers: A Population-Based Cohort Study
Zhongxiao Wan, Xiaohui Zhang, Huanying He, et al.
Neuroepidemiology (2024) Vol. 58, Iss. 3, pp. 166-173
Closed Access | Times Cited: 2
Introducing a brain health literacy framework to promote health equity for Latinos: A discussion paper
Sophia W. Light, Alissa Bernstein Sideman, Alyssa Vela, et al.
Patient Education and Counseling (2024) Vol. 124, pp. 108254-108254
Closed Access | Times Cited: 2
Analysis of ADORA2A rs5760423 and CYP1A2 rs762551 Genetic Variants in Patients with Alzheimer’s Disease
Vasileios Siokas, Dimitra S. Mouliou, Ioannis Liampas, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14400-14400
Open Access | Times Cited: 12
Disclosure of Genetic Risk Factors for Alzheimer’s Disease to Cognitively Healthy Individuals—From Current Practice towards a Personalised Medicine Scenario
Samantha Galluzzi, Michela Pievani, Orazio Zanetti, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3177-3177
Open Access | Times Cited: 11
Development and Concurrent Validity of the Short-Form CogDrisk Dementia Risk Assessment Tool
Kaarin J. Anstey, Md Hamidul Huque, Scherazad Kootar, et al.
The Journal of Prevention of Alzheimer s Disease (2024)
Closed Access | Times Cited: 1
Incremental Value of Multidomain Risk Factors for Dementia Prediction: A Machine Learning Approach
Wei Ying Tan, Carol Anne Hargreaves, Gavin S. Dawe, et al.
American Journal of Geriatric Psychiatry (2024) Vol. 33, Iss. 3, pp. 229-244
Closed Access | Times Cited: 1
A Comprehensive Review of Modifiable Cardiovascular Risk Factors and Genetic Influences in Dementia Prevention
Mariam Khan, Arpita Jaiswal, Bhushan Wandile
Cureus (2023)
Open Access | Times Cited: 4
Longitudinal Association of Mid-Life Ten Year Cardiovascular Disease Risk Score with Brain Biomarkers of Alzheimer’s Disease, Neurodegeneration and White Matter Hyper Intensities in Cognitively Unimpaired Older Adults: Heart SCORE Brain Study
Anum Saeed, Yue‐Fang Chang, Justin Swanson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Genomic Insights into Dementia: Precision Medicine and the Impact of Gene-Environment Interaction
Anjali Tripathi, Vinay Kumar Pandey, Garima Sharma, et al.
Aging and Disease (2024) Vol. 15, Iss. 5, pp. 2113-2113
Open Access | Times Cited: 1
Barriers and facilitators to implementation of physical activity programs for individuals with dementia living in aged care homes: a systematic review
Mitchell Andrews, Birinder S. Cheema, Joyce Siette
Archives of Gerontology and Geriatrics (2024) Vol. 126, pp. 105535-105535
Open Access | Times Cited: 1
Subclinical hyperthyroidism and the risk of dementia: A meta‐analysis
Qiao Liu, Chaoyin Lu, Mengdie Chen, et al.
Brain and Behavior (2024) Vol. 14, Iss. 9
Open Access | Times Cited: 1
Altered Balance of Reelin Proteolytic Fragments in the Cerebrospinal Fluid of Alzheimer’s Disease Patients
Inmaculada López‐Font, Matthew P. Lennol, Guillermo Iborra‐Lázaro, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7522-7522
Open Access | Times Cited: 7
Prevention and health promotion in dementia: motivation for change within preventive interventions—Empirical results
Jochen René Thyrian
Der Nervenarzt (2023) Vol. 94, Iss. 5, pp. 375-383
Closed Access | Times Cited: 2
Reply: Unblinding in the lecanemab trial in Alzheimer’s disease
John Hardy, Catherine J. Mummery
Brain (2023) Vol. 146, Iss. 11, pp. e101-e101
Open Access | Times Cited: 2
Reducing Dementia Risk: The Latest Evidence to Guide Conversations With Older Adults
Justin Do, Nikki L. Hill
Journal of Gerontological Nursing (2023) Vol. 49, Iss. 9, pp. 3-5
Closed Access | Times Cited: 2
Serum Cathepsin D Is a Potential Biomarker for Alzheimer’s Disease Dementia and Cognitive Decline
Yuek Ling Chai, Nathan Hao Ping Liang, Joyce R. Chong, et al.
Journal of Alzheimer s Disease (2022) Vol. 91, Iss. 3, pp. 989-998
Closed Access | Times Cited: 4
The European Prevention of Alzheimer's Dementia Programme: An Innovative Medicines Initiative-funded partnership to facilitate secondary prevention of Alzheimer's disease dementia
Stina Saunders, Sarah Gregory, Matthew H. S. Clement, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 3
The association between low cognitive reserve and subjective memory complaints in functionally independent older women
Rosalinda Sánchez‐Arenas, Renata Buenfil-Fuentes, Claudia Dı́az-Olavarrieta, et al.
Experimental Gerontology (2022) Vol. 172, pp. 112061-112061
Open Access | Times Cited: 3

Scroll to top